SBIR-STTR Award

Device for Otitis Media Diagnosis
Award last edited on: 1/18/2018

Sponsored Program
SBIR
Awarding Agency
NIH : NIDCD
Total Award Amount
$1,146,435
Award Phase
2
Solicitation Topic Code
-----

Principal Investigator
Mark A Moehring

Company Information

Otonexus Medical Technologies Inc (AKA: OtoMetrix Medical Technologies, Inc)

1546 NW 56th Street
Seattle, WA 98107
   (206) 330-0610
   info@otonexus.com
   www.otonexus.com
Location: Single
Congr. District: 07
County: King

Phase I

Contract Number: 1R44DC015147-01A1
Start Date: 9/1/2016    Completed: 2/28/2017
Phase I year
2016
Phase I Amount
$147,876
Device for Otitis Media Diagnosis OtoNexus is developing the world's first medical device to provide definitive, objective diagnostic data for the rapid and accurate diagnose middle ear infections, called Otitis Media, in children and adults. This FAST TRACK proposal addresses the clinical difficulty of determining the nature of fluid behind the tympanic membrane (ear drum) in acute infection of the middle ear (Acute Otitis Media - AOM). Clinical studies show that error rates (false negative, false positive) among young physicians average 50%. Accurate detection of AOM depends on detecting and characterizing middle ear fluid. Experienced examiners realize they err in at least 20% of cases even when pneumatic otoscopy is used. Medical practitioners diagnose 17.6M cases of Otitis Media each year at a cost of more than $5 billion in the US. Current diagnostic methods are decades old, highly subjective, and extremely ineffective. Consequently, Otitis Media is both the #1 indication for antibiotic prescriptions in children and the #1 cause for surgery for children. Each year, 667,000 children under 15 receive tympanostomy tubes, accounting for more than 20% of all ambulatory surgery in this group. Excessive antibiotic treatment from over-diagnosis of OM can lead to antibiotic resistance, significant side effects, and increased drug costs. Under-diagnosis can allow the infection to progress, potentially requiring surgery or risking permanent hearing loss. We propose to use Doppler Ultrasound (DUS) to judge the oscillation of the tympanic membrane (TM) after perturbing the membrane position. Membrane mobility is reduced with increasing fluid viscosity. DUS permits a fast and systematic evaluation of this mobility. The proposed device can be used by physician and assistant alike. DUS data can readily affirm the presence of middle ear effusion and estimate its nature. The present project is the basic step to determine the most efficient parameters for assessing TM mobility and therefore the presence and character of middle ear effusion (Phase I), and then integrate the device into a hand-held form factor suitable for testing and commercialization (Phase II). Model TM motions will be observed by DUS with a novel transducer to assess contents of the phantom middle ear, and guide the development of signal processing to distinguish membrane mobility. The device is expected to increase prognostic accuracy, largely eliminate diagnostic uncertainty and resultant over-prescription of antibiotics, reduce unnecessary specialist referrals, reduce instances of hearing loss damage, and place the tools for accurate diagnosis of OM into the hands of the very first clinician the child sees. !

Public Health Relevance Statement:
Narrative Project Narrative –"“Device for Otitis Media Diagnosis” The diagnosis of middle ear infection (Otitis Media) in infants and children is difficult and imprecise, leading to increased health care costs and overuse of antibiotics, resulting in resistant organisms. The proposed device will use novel ultrasound technology to examine for the presence and character of fluid in the middle ear (the hallmark of infection), resulting in increased diagnostic accuracy and supporting rationale for treatment. The examination will be painless, quick, and accurate; this device will be the first new advance in middle ear examination in four decades. "

Project Terms:
abstracting; Academy; Accounting; accurate diagnosis; Acute; Address; Adult; Adverse effects; Air; Ambulatory Surgical Procedures; American; Antibiotic Resistance; Antibiotic Therapy; Antibiotics; base; Child; Childhood; Chronic; Clinical; Clinical Research; Code; commercialization; cost; Custom; Data; design; Detection; detector; Development; Devices; Diagnosis; Diagnostic; diagnostic accuracy; Diagnostic Errors; Diagnostic Procedure; Doppler Ultrasound; Drug Costs; ear infection; Ear structure; effusion; Elements; engineering design; Enrollment; Environment; Evaluation; experience; External auditory canal structure; External Ear; Grant; Graph; Guidelines; Hand; Health Care Costs; Health Professional; hearing impairment; Industry Standard; Infant; Infection; Inflammation; instrumentation; Lead; Liquid substance; Measurement; Mechanics; Medical; Medical Device; Membrane; middle ear; Modeling; Motion; Nature; novel; Nurses; Operative Surgical Procedures; Organism; Otitis Media; Otitis Media with Effusion; Otoscopy; outcome forecast; Output; Painless; Patients; Pediatrics; Perforation; Performance; phantom model; Phase; Physician Assistants; Physicians; Positioning Attribute; preference; pressure; primary caregiver; Production; prognostic; Program Development; prototype; Qualifying; rapid diagnosis; Research; research clinical testing; research study; Resistance; Response to stimulus physiology; Risk; signal processing; Signal Transduction; Specialist; Speed; success; System; Technology; Testing; Time; tool; Transducers; Tube; Tympanic membrane structure; Tympanostomy; Tympanostomy Tube Insertions; Ultrasonic Transducer; Ultrasonography; Uncertainty; usability; Viscosity; Visit

Phase II

Contract Number: 4R44DC015147-02
Start Date: 9/1/2016    Completed: 6/30/2019
Phase II year
2017
(last award dollars: 2018)
Phase II Amount
$998,559

OtoNexus is developing the world’s first medical device to provide definitive, objective diagnostic data for the rapid and accurate diagnose middle ear infections, called Otitis Media, in children and adults. This FAST TRACK proposal addresses the clinical difficulty of determining the nature of fluid behind the tympanic membrane (ear drum) in acute infection of the middle ear (Acute Otitis Media - AOM). Clinical studies show that error rates (false negative, false positive) among young physicians average 50%. Accurate detection of AOM depends on detecting and characterizing middle ear fluid. Experienced examiners realize they err in at least 20% of cases even when pneumatic otoscopy is used. Medical practitioners diagnose 17.6M cases of Otitis Media each year at a cost of more than $5 billion in the US. Current diagnostic methods are decades old, highly subjective, and extremely ineffective. Consequently, Otitis Media is both the #1 indication for antibiotic prescriptions in children and the #1 cause for surgery for children. Each year, 667,000 children under 15 receive tympanostomy tubes, accounting for more than 20% of all ambulatory surgery in this group. Excessive antibiotic treatment from over-diagnosis of OM can lead to antibiotic resistance, significant side effects, and increased drug costs. Under-diagnosis can allow the infection to progress, potentially requiring surgery or risking permanent hearing loss. We propose to use Doppler Ultrasound (DUS) to judge the oscillation of the tympanic membrane (TM) after perturbing the membrane position. Membrane mobility is reduced with increasing fluid viscosity. DUS permits a fast and systematic evaluation of this mobility. The proposed device can be used by physician and assistant alike. DUS data can readily affirm the presence of middle ear effusion and estimate its nature. The present project is the basic step to determine the most efficient parameters for assessing TM mobility and therefore the presence and character of middle ear effusion (Phase I), and then integrate the device into a hand-held form factor suitable for testing and commercialization (Phase II). Model TM motions will be observed by DUS with a novel transducer to assess contents of the phantom middle ear, and guide the development of signal processing to distinguish membrane mobility. The device is expected to increase prognostic accuracy, largely eliminate diagnostic uncertainty and resultant over-prescription of antibiotics, reduce unnecessary specialist referrals, reduce instances of hearing loss damage, and place the tools for accurate diagnosis of OM into the hands of the very first clinician the child sees.

Public Health Relevance Statement:
The diagnosis of middle ear infection (Otitis Media) in infants and children is difficult and imprecise, leading to increased health care costs and overuse of antibiotics, resulting in resistant organisms. The proposed device will use novel ultrasound technology to examine for the presence and character of fluid in the middle ear (the hallmark of infection), resulting in increased diagnostic accuracy and supporting rationale for treatment. The examination will be painless, quick, and accurate; this device will be the first new advance in middle ear examination in four decades.

Project Terms:
Academy; Accounting; accurate diagnosis; Acute; Address; Adult; Adverse effects; Air; Ambulatory Surgical Procedures; American; Antibiotic Resistance; Antibiotic Therapy; Antibiotics; base; Child; Childhood; Chronic; Clinical; Clinical Research; Code; commercialization; cost; Custom; Data; design; Detection; detector; Development; Devices; Diagnosis; Diagnostic; diagnostic accuracy; Diagnostic Errors; Diagnostic Procedure; Doppler Ultrasound; Drug Costs; Ear; ear infection; effusion; Elements; engineering design; Enrollment; Environment; Evaluation; experience; experimental study; External auditory canal; External Ear; Grant; Graph; Guidelines; Hand; Health Care Costs; Health Professional; hearing impairment; Industry Standard; Infant; Infection; Inflammation; instrumentation; Lead; Liquid substance; Measurement; Mechanics; Medical; Medical Device; Membrane; middle ear; Modeling; Motion; Nature; novel; Nurses; Operative Surgical Procedures; Organism; Otitis Media; Otitis Media with Effusion; Otoscopy; outcome forecast; Output; Painless; Patients; Pediatrics; Perforation; Performance; phantom model; Phase; Physician Assistants; Physicians; Positioning Attribute; preference; pressure; primary caregiver; prognostic; Program Development; programs; prototype; rapid diagnosis; Research; research clinical testing; Resistance; Response to stimulus physiology; Risk; signal processing; Signal Transduction; Specialist; Speed; success; System; Technology; Testing; Time; tool; Transducers; Tube; Tympanic membrane; Tympanostomy; Tympanostomy Tube Insertions; Ultrasonic Transducer; Ultrasonography; Uncertainty; usability; Viscosity; Visit